ASO Author Reflections: Colorectal Cancer Patients with Peritoneal Metastases and Other Metastatic Sites Can Benefit from Radical Multifocal Treatment After Comprehensive Evaluation for Accurate Selection
暂无分享,去创建一个
[1] O. Glehen,et al. Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases , 2023, Annals of Surgical Oncology.
[2] O. Glehen,et al. Advances in the management of peritoneal malignancies , 2022, Nature Reviews Clinical Oncology.
[3] M. Pocard,et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. , 2021, The Lancet. Oncology.
[4] V. Heinemann,et al. Pattern and Dynamics of Distant Metastases in Metastatic Colorectal Cancer , 2017, Visceral Medicine.
[5] C. Tournigand,et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. , 2016, The Lancet. Oncology.